DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Gadoxetic acid

Gadoxetic acid

  • List of Union Reference Dates A

    List of Union Reference Dates A

  • Gadolinium Based Contrast Agents

    Gadolinium Based Contrast Agents

  • Advisory Committee Briefing Document Medical Imaging Drugs Advisory Committee (MIDAC) September 8, 2017

    Advisory Committee Briefing Document Medical Imaging Drugs Advisory Committee (MIDAC) September 8, 2017

  • Estonian Statistics on Medicines 2016 1/41

    Estonian Statistics on Medicines 2016 1/41

  • Injection of Contrast Media V7 – 2010 13 5

    Injection of Contrast Media V7 – 2010 13 5

  • Art. 31 Gadolinium

    Art. 31 Gadolinium

  • Public Assessment Report for Paediatric Studies Submitted in Accordance with Article 46 of Regulation (EC) No1901/2006, As Amended

    Public Assessment Report for Paediatric Studies Submitted in Accordance with Article 46 of Regulation (EC) No1901/2006, As Amended

  • Active Moiety Name FDA Established Pharmacologic Class (EPC) Text

    Active Moiety Name FDA Established Pharmacologic Class (EPC) Text

  • PART VI Summary of Activities in the Risk Management Plan by Product

    PART VI Summary of Activities in the Risk Management Plan by Product

  • Application for Inclusion of Gadolinium-Based Contrast Agents to the WHO

    Application for Inclusion of Gadolinium-Based Contrast Agents to the WHO

  • Estonian Statistics on Medicines 2013 1/44

    Estonian Statistics on Medicines 2013 1/44

  • Environmentally Classified Pharmaceuticals 2014-2015

    Environmentally Classified Pharmaceuticals 2014-2015

  • Use of Cardiotrophin-1 for the Treatment of Kidney Diseases

    Use of Cardiotrophin-1 for the Treatment of Kidney Diseases

  • DTPA-Enhanced MRI ⇑ Laura Fernandez-De-Manuel A,B, , Gert Wollny A,B, Jan Kybic C, Daniel Jimenez-Carretero A,B, Jose M

    DTPA-Enhanced MRI ⇑ Laura Fernandez-De-Manuel A,B, , Gert Wollny A,B, Jan Kybic C, Daniel Jimenez-Carretero A,B, Jose M

  • Chapter 138A Pharmacy and Poison Regulations.Pdf

    Chapter 138A Pharmacy and Poison Regulations.Pdf

  • FDA Listing of Established Pharmacologic Class Text Phrases January 2021

    FDA Listing of Established Pharmacologic Class Text Phrases January 2021

  • Stembook 2018.Pdf

    Stembook 2018.Pdf

  • Diagnostic Performance of Gadoxetic Acid

    Diagnostic Performance of Gadoxetic Acid

Top View
  • (12) Patent Application Publication (10) Pub. No.: US 2016/0348103 A1 WHEELER Et Al
  • Gadolinium Containing Contrast Agents
  • Gadoxetic Acid (Rinn) Preparations Acide Gadoxétique; Ácido Gadoxético; Acidum Gadoxeticum; Pharmacopoeias
  • Manual on Contrast Media Version 7 2010
  • WO 2017/222911 A1 (.Pdf)
  • Diagnostic Accuracy of Gadoxetic Acid-Enhanced MR for Small Hypervascular Hepatocellular Carcinoma and the Concordance Rate of Liver Imaging Reporting and Data System (LI-RADS)
  • Biem Pharmaceuticals Is
  • Provisional Peer-Reviewed Toxicity Values for Stable (Nonradioactive) Gadolinium (Casrn 7440-54-2) and Soluble Salts
  • Atc Index 2010
  • WO 2014/153118 Al 25 September 2014 (25.09.2014) P O P C T
  • Comprehensive Contrast Policy Page 2 of 25
  • Gadoxetic Acid–Enhanced Magnetic Resonance Imaging and Contrast
  • Pharmacologyonline 3: 728-781 (2010) Newsletter Bradu and Rossini
  • Superparamagnetic Iron Oxide Nanoparticles in Biomedicine
  • Safety and Clinical Usefulness of Gadoteric Acid Including Post-Marketing Surveillance
  • Harmonized Tariff Schedule of the United States (2006) (Rev
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
  • Smart MRI Agents for Detecting Extracellular Events in Vivo: Progress and Challenges


© 2024 Docslib.org    Feedback